Tap into industry expertise in HRMS/NanoLC to reveal deeper disease mechanisms, improve monitoring, and speed targeted therapies.
Watch the webinar instantly.
Nilo Therapeutics, which launched Wednesday, is trying to develop drugs that regulate inflammation and the immune system by targeting a special kind of nerve cell.
The findings are the latest setback for weight loss medicines that target a specific cannabinoid receptor and are meant to boost the effects of incretin therapies like Wegovy.
The agency will consider a submission that includes pooled data from ongoing studies, a decision analysts viewed as a notable, additional sign of regulatory flexibility for gene therapies.
Six months after his abrupt resignation as CBER director, Marks has been hired to run discovery and infectious disease work at the big Indianapolis drugmaker.
The results could pave the way for Datroway to supplant chemotherapy in certain triple-negative tumors, adding to existing clearances in other breast and lung malignancies.
Pharma leaders investing millions in events often lack visibility into cross-meeting engagement patterns that could maximize ROI. Explore a data approach that turns attendee insights into advantages in this playbook.
